Cosmetic Safety Enhancement Act of 2019

Fact Sheet API

Bill Number

HR 5279

Introduced

Dec 3, 2019

Latest Action

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

Sponsor

Cosponsors

Topics

Animal protection and human-animal relationships Business records Congressional oversight Consumer affairs Cosmetics and personal care Drug safety, medical device, and laboratory regulation Government information and archives Health Inflation and prices Internet and video services Internet, web applications, social media Licensing and registrations Manufacturing Performance measurement Product safety and quality User charges and fees

Full Text

View Full Bill Text

Votes

Summary

Cosmetic Safety Enhancement Act of 2019

This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.

Actions

Mar 11, 2020

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Mar 11, 2020

Subcommittee Consideration and Mark-up Session Held.
Dec 4, 2019

Referred to the Subcommittee on Health.
Dec 3, 2019

Referred to the House Committee on Energy and Commerce.
Dec 3, 2019

Introduced in House

Amendments

Related Bills